Wilson Sonsini is pleased to be a 2025 sponsor of the Pharmaceutical and Biomedical Sciences Society International (PBSS).
This event introduces career paths that connect science and law, highlighting the experiences of PhD-trained professionals who have moved from research scientist roles into IP and technology transactions. Speakers from Wilson Sonsini, Gilead, and PTM Therapeutics will discuss their journeys and current roles.
Wilson Sonsini partner Julia Minitti will present "Scientists in Big Law," and firm patent agent Julia Kennedy-Darling will present "From Biotech Innovation to Patent Agent," in addition, firm associate Kexi Wang will present "The Intersection of Science and Transaction: A Career in Technology Transactions. "
The event concludes with a panel discussion where presenters are brought together to offer practical advice and answer questions about navigating a transition to the legal side of science.
Katie Stonum
kstonum@wsgr.com
Julia Minitti is a partner in Wilson Sonsini's patent and innovation strategies practice.
Julia Kennedy-Darling is a patent agent in the Palo Alto office of Wilson Sonsini Goodrich & Rosati, where she focuses on patent prosecution and other IP due diligence matters. She has experience in chemical biology, in vitro DNA assay development, spatial biology, mass spectrometry, and immunology.
Dr. Kexi Wang is an associate in the Shanghai office of Wilson Sonsini Goodrich & Rosati, where her practice focuses on technology transactions and corporate law. Prior to attending law school, Kexi conducted doctoral research on the regulatory mechanism of mitosis, where she gained research experience in cell biology, molecular biology, and biochemistry.